Ensign Peak Advisors
ABMD

Ensign Peak Advisors’s Abiomed Inc ABMD Stock Holding History

Ensign Peak Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,596
Closed -$2.85M – 2330
2022
Q3 		$2.85M Hold
11,596
– – 0.01% 669
2022
Q2 		$2.87M Buy
11,596
+835
+8% +$225K 0.01% 686
2022
Q1 		$3.56M Sell
10,761
-2,470
-19% -$760K 0.01% 681
2021
Q4 		$4.75M Buy
13,231
+9,650
+269% +$3.26M 0.01% 678
2021
Q3 		$1.17M Sell
3,581
-1,374
-28% -$465K ﹤0.01% 1375
2021
Q2 		$1.55M Buy
4,955
+195
+4% +$59.8K ﹤0.01% 1251
2021
Q1 		$1.52M Sell
4,760
-1,970
-29% -$630K ﹤0.01% 1243
2020
Q4 		$2.18M Buy
6,730
+1,055
+19% +$292K ﹤0.01% 1012
2020
Q3 		$1.57M Sell
5,675
-3,765
-40% -$1.08M ﹤0.01% 1099
2020
Q2 		$2.28M Sell
9,440
-2,210
-19% -$444K 0.01% 901
2020
Q1 		$1.69M Sell
11,650
-2,887
-20% -$479K 0.01% 920
2019
Q4 		$2.48M Buy
+14,537
New +$2.7M 0.01% 956

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ensign Peak Advisors's ABMD Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 11,596 shares — an estimated $2.85M sold.

Ensign Peak Advisors first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $4.75M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 11,596 Abiomed Inc shares in Q4 2022, an estimated $2.85M.
  • Ensign Peak Advisors first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Ensign Peak Advisors's Abiomed Inc position peaked at $4.75M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.